HopeStage
Back to all studies
CompletedNCT00034905

Quetiapine or risperidone for schizophrenia

About this titleRead the official source — NCT00034905
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Birmingham and 63 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2001
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00034905
Official title
Show the full official title

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Phoenix · Anaheim

61 more locations
  • Cerritos
  • Chula Vista
  • Glendale
  • Hawthorne
  • Long Beach
  • San Diego
  • Santa Ana
  • Torrance
  • Farmington
  • New Haven
  • Washington D.C.
  • Miami
  • Miami Beach
  • North Miami
  • Winter Park
  • Atlanta
  • Hoffman Estates
  • Prairie Village
  • Wichita
  • New Orleans
  • Shreveport
  • Baltimore
  • Boston
  • Worcester
  • Ann Arbor
  • New Baltimore
  • Kansas City
  • St Louis
  • Reno
  • Clementon
  • Lyons
  • Summit
  • Albuquerque
  • Holliswood
  • Montrose
  • New York
  • Oceanside
  • The Bronx
  • White Plains
  • Butner
  • Beachwood
  • Chagrin Falls
  • Cincinnati
  • Columbus
  • Oklahoma City
  • Media
  • Pittsburgh
  • Memphis
  • Nashville
  • Austin
  • Houston
  • Terrell
  • Waco
  • Salt Lake City
  • Falls Church
  • Richmond
  • Virginia Beach
  • Kirkland
  • Tacoma
  • Vancouver
  • West Allis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Did this study involve medication?

Yes. The study involved medication, including quetiapine fumarate vs risperidone.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies